038070 — Seoulin Bioscience Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩58bn
- KR₩39bn
- KR₩75bn
Annual cashflow statement for Seoulin Bioscience Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 4,801 | 15,768 | 9,977 | -2,323 | 3,140 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 1,056 | -7,437 | -1,291 | 8,168 | -982 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -4,156 | -1,343 | -14,059 | -6,201 | -8,135 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 3,684 | 8,918 | -4,356 | 931 | -4,611 |
| Capital Expenditures | -943 | -1,670 | -707 | -974 | -62.4 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 1,652 | -29,829 | -1,958 | 28,500 | 6,452 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 709 | -31,499 | -2,665 | 27,526 | 6,389 |
| Financing Cash Flow Items | 402 | -29,008 | -1,077 | — | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -402 | 29,008 | 1,077 | -22,778 | -7,453 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3,955 | 6,475 | -5,974 | 5,603 | -5,653 |